Prospective, Multicentre, Open-label Study Evaluating 1.5 mg/Day of Fondaparinux.

Clinical trial NCT00555438 · COMPLETED

Trial details

NCT number: NCT00555438
Sponsor: Centre Hospitalier Universitaire de Saint Etienne
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Major Orthopaedic Surgery and Renal Impairment

Start date: 2007-06-01
Primary completion: 2008-10-01
Enrollment: 451

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.